Page last updated: 2024-11-07

2-amino-5-hydroxyvaleric acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-amino-5-hydroxyvaleric acid: a specific marker of oxidized arginine and proline residues in proteins; RN given refers to cpd without isomeric designation; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID95562
CHEBI ID165867
SCHEMBL ID59755
MeSH IDM0045464

Synonyms (42)

Synonym
5-hydroxynorvaline
nsc20896 ,
533-88-0
norvaline, 5-hydroxy-
nsc-20896
.delta.-hydroxynorvaline
2-amino-5-hydroxypentanoic acid
hydroxyvaline
pentahomoserine
.alpha.-amino-.delta.-hydroxyvaleric cid
nsc206265
l-.alpha.-amino-.delta.-hydroxyvaleric acid
.alpha.-amino-.delta.-hydroxyvalerate
nsc-206265
CHEBI:165867
l-2-amino-5-hydroxypentanoic acid
2-amino-5-hydroxyvaleric acid
hava-5 cpd
delta-hydroxynorvaline
nsc 20896
pkg8i0m67e ,
alpha-amino-delta-hydroxyvaleric acid
5-hydroxy-2-aminovalerate
5-oh-2-nh2-valerate
unii-pkg8i0m67e
FT-0689993
AKOS015892690
SCHEMBL59755
norvaline, 5-hydroxy-, l-
CZWARROQQFCFJB-UHFFFAOYSA-N
pentahomoserine [mi]
pentahomoserine, (+/-)-
.alpha.-amino-.delta.-hydroxyvaleric acid
5-hydroxy-dl-norvaline
dl-.delta.-hydroxy-.alpha.-aminovaleric acid
pentahomoserine dl-form [mi]
mfcd00078391
Q27286597
SY269711
2-amino-5-hydroxypentanoicacid
DTXSID901315938
EN300-84934
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
alpha-amino acidAn amino acid in which the amino group is located on the carbon atom at the position alpha to the carboxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (35.00)18.7374
1990's5 (25.00)18.2507
2000's7 (35.00)29.6817
2010's1 (5.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.13

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.13 (24.57)
Research Supply Index3.09 (2.92)
Research Growth Index4.22 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.13)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.76%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (95.24%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]